RocketTickers

Eton Pharmaceuticals Announces FDA Approval of Rezipres® (Ephedr

Long
NASDAQ:ETON   Eton Pharmaceuticals, Inc.
ETON: Eton Pharmaceuticals
2021-06-15 10:37:52
Eton Pharmaceuticals Announces FDA Approval of Rezipres® (Ephedrine Hydrochloride Injection)
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.